Evidence map›Paper›PMID 26070402›Full record

ReviewTrends in parasitology2015

Chew on this: amoebic trogocytosis and host cell killing by Entamoeba histolytica.

Katherine S Ralston

Abstract readReview
In one paragraph

Review in Trends in parasitology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Interactions ofMicrobiology spectrum · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. The Biological Significance of Trogocytosis.Results and problems in cell differentiation · 2024
    Article
  6. Review
  7. Aptamer-based approaches for the detection of waterborne pathogens.International microbiology : the official journal of the Spanish Society for Microbiology · 2021
    Review
  8. Review
  9. Review
  10. Revisiting the Mechanisms of Immune Evasion Employed by Human Parasites.Frontiers in cellular and infection microbiology · 2021
    Review
  11. Article
  12. Article
  13. Revisiting Drug Development Against the Neglected Tropical Disease, Amebiasis.Frontiers in cellular and infection microbiology · 2020
    Review
  14. Article
  15. Article
  16. Reassessing the Role ofFrontiers in cellular and infection microbiology · 2018
    Review
  17. Article
  18. Article
  19. Recent advances inF1000Research · 2016
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Katherine S RalstonDepartment of Microbiology and Molecular Genetics, University of California, Davis, CA 95616, USA. Electronic address: ksralston@ucdavis.edu.

Funding

"Biting" of human cells by Entamoeba histolytica: a novel cytotoxic mechanismK22AI108814 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI RALSTON, KATHERINE S · 2015 to 2016
$268k
NIAID NIH HHS 1K22AI108814NIAID NIH HHS K22 AI108814
6 · The paper itself

Abstract

Entamoeba histolytica was named 'histolytica' (from histo-, 'tissue'; lytic-, 'dissolving') for its ability to destroy host tissues. Direct killing of host cells by the amoebae is likely to be the driving factor that underlies tissue destruction, but the mechanism was unclear. We recently showed that, after attaching to host cells, amoebae bite off and ingest distinct host cell fragments, and that this contributes to cell killing. We review this process, termed 'amoebic trogocytosis' (trogo-, 'nibble'), and how this process interplays with phagocytosis, or whole cell ingestion, in this organism. 'Nibbling' processes have been described in other microbes and in multicellular organisms. The discovery of amoebic trogocytosis in E. histolytica may also shed light on an evolutionarily conserved process for intercellular exchange.

Indexed as

AnimalsCell ShapeCell SizeCell SurvivalEntamoeba histolyticaEntamoebiasisHost-Parasite InteractionsHumansPhagocytosiscell deathcytotoxicEntamoebaphagocytosistrogocytosis

Identifiers

PMID26070402
PMCPMC4567409

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.